Yubo International Biotech Ltd Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Yubo International Biotech Ltd quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2020 to Q2 2024.
  • Yubo International Biotech Ltd Deferred Tax Assets, Valuation Allowance for the quarter ending June 30, 2024 was $1.29M, a 40.3% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $1.29M +$371K +40.3% Jun 30, 2024 10-Q 2024-08-19
Q1 2024 $1.15M +$309K +36.7% Mar 31, 2024 10-Q 2024-05-20
Q4 2023 $1.05M +$288K +37.7% Dec 31, 2023 10-Q 2024-08-19
Q3 2023 $910K +$99.6K +12.3% Sep 30, 2023 10-Q 2023-11-20
Q2 2023 $922K +$170K +22.6% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $841K +$207K +32.6% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $763K +$271K +55.1% Dec 31, 2022 10-K 2024-04-12
Q3 2022 $810K +$391K +93.1% Sep 30, 2022 10-Q 2022-11-16
Q2 2022 $752K +$415K +123% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $634K +$914K Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $492K +$285K +138% Dec 31, 2021 10-K 2023-04-14
Q3 2021 $420K Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $337K Jun 30, 2021 10-Q 2021-08-20
Q1 2021 -$279K Mar 31, 2021 10-Q 2021-05-24
Q4 2020 $207K Dec 31, 2020 10-K 2022-04-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.